Annual report

Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥132.1bn2021-04-01 → 2022-03-31Cons.Net sales
Revenue¥146.8bn2020-04-01 → 2021-03-31Cons.Net sales
Revenue¥133.4bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Revenue¥129.8bn2018-04-01 → 2019-03-31dCons.Net sales (5-year summary)
Revenue¥128.9bn2017-04-01 → 2018-03-31dCons.Net sales (5-year summary)
Operating income¥22.7bn2021-04-01 → 2022-03-31Cons.Operating income
Operating income¥19.8bn2020-04-01 → 2021-03-31Cons.Operating income
Ordinary income¥23.4bn2021-04-01 → 2022-03-31Cons.Ordinary income
Ordinary income¥20.3bn2020-04-01 → 2021-03-31Cons.Ordinary income
Ordinary income¥13.6bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥13.3bn2018-04-01 → 2019-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥12.7bn2017-04-01 → 2018-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥23.7bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Profit before tax¥21.0bn2020-04-01 → 2021-03-31Cons.Income before income taxes
Net income (owners)¥16.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥14.7bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.6bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.6bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.3bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥16.2bn2021-04-01 → 2022-03-31Cons.Profit loss
Net income¥14.7bn2020-04-01 → 2021-03-31Cons.Profit loss
Total assets¥195.5bnat 2022-03-31Cons.Assets
Total assets¥191.8bnat 2021-03-31Cons.Assets
Total assets¥168.7bnat 2020-03-31dCons.Total assets (5-year summary)
Total assets¥160.9bnat 2019-03-31dCons.Total assets (5-year summary)
Total assets¥157.5bnat 2018-03-31dCons.Total assets (5-year summary)
Total liabilities¥45.6bnat 2022-03-31Cons.Liabilities
Total liabilities¥53.8bnat 2021-03-31Cons.Liabilities
Net assets / equity¥149.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥138.0bnat 2021-03-31Cons.Net assets
Net assets / equity¥124.4bnat 2020-03-31dCons.Net assets
Net assets / equity¥119.2bnat 2019-03-31dCons.Net assets (5-year summary)
Net assets / equity¥113.3bnat 2018-03-31dCons.Net assets (5-year summary)
Cash and deposits¥64.1bnat 2022-03-31Cons.Cash and deposits
Cash and deposits¥56.6bnat 2021-03-31Cons.Cash and deposits
Cash & equivalents¥61.0bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥53.6bnat 2021-03-31Cons.Cash and cash equivalents
Cash & equivalents¥46.1bnat 2020-03-31dCons.Cash and cash equivalents
Cash & equivalents¥43.8bnat 2019-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥43.4bnat 2018-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥23.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥21.7bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥20.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥14.0bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥17.9bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥10.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥11.3bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥14.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥10.6bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.8bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥4.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.0bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.7bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.0bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.8bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥1,072.382021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥973.332020-04-01 → 2021-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥633.032019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥629.372018-04-01 → 2019-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥612.492017-04-01 → 2018-03-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥9,909.4at 2022-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥9,125.88at 2021-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥8,229.96at 2020-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥7,831.61at 2019-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥7,442.43at 2018-03-31dCons.Net assets per share (5-year summary)
Equity ratio76.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.0%at 2021-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio74.1%at 2019-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio71.9%at 2018-03-31dCons.Equity to asset ratio (5-year summary)
ROE11.3%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
ROE11.2%2020-04-01 → 2021-03-31Cons.Rate of return on equity (5-year summary)
ROE7.9%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
ROE8.2%2018-04-01 → 2019-03-31dCons.Rate of return on equity (5-year summary)
ROE8.5%2017-04-01 → 2018-03-31dCons.Rate of return on equity (5-year summary)
Employees3,348at 2022-03-31Cons.Number of employees
Employees3,291at 2021-03-31Cons.Number of employees
Employees3,208at 2020-03-31dCons.Number of employees
Employees3,121at 2019-03-31dCons.Number of employees
Employees3,132at 2018-03-31dCons.Number of employees
Revenue¥82.5bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥81.8bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥71.8bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥71.6bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥71.0bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥12.7bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥11.5bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥18.0bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥15.0bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥9.9bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥12.0bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥10.6bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥18.5bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥15.8bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥14.4bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥12.0bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥8.0bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥9.5bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥8.9bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥163.5bnat 2022-03-31StandaloneAssets
Total assets¥158.1bnat 2021-03-31StandaloneAssets
Total assets¥137.3bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥131.4bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥127.8bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥46.5bnat 2022-03-31StandaloneLiabilities
Total liabilities¥50.9bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥117.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥107.2bnat 2021-03-31StandaloneNet assets
Net assets / equity¥96.7bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥92.8bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥86.8bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥41.3bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥33.3bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥955.22021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥794.032020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥529.62019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥625.92018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥584.212017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥3052021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥2752020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1802019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1752018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1702017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥7,742.42at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥7,087.89at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥6,398.56at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥6,096.47at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥5,702.49at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio71.6%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio67.8%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio70.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.6%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio67.9%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE12.9%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE11.8%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE8.5%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE10.6%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE10.7%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued19,588,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,588,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,588,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued19,588,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued19,588,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees669at 2022-03-31StandaloneNumber of employees
Employees659at 2021-03-31StandaloneNumber of employees
Employees651at 2020-03-31dStandaloneNumber of employees
Employees629at 2019-03-31dStandaloneNumber of employees
Employees650at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 64
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥93.5bn
Consumables And Other Productsreportable segmentcapex2021-04-01 → 2022-03-31¥1.8bn
Consumables And Other Productsreportable segmentdepreciation2021-04-01 → 2022-03-31¥593m
Consumables And Other Productsreportable segmentrevenue2021-04-01 → 2022-03-31¥35.2bn
Consumables And Other Productsreportable segmentrevenue external2021-04-01 → 2022-03-31¥35.2bn
Consumables And Other Productsreportable segmentsegment assetsat 2022-03-31¥24.1bn
Consumables And Other Productsreportable segmentsegment profit2021-04-01 → 2022-03-31¥5.1bn
Medical Treatment Equipmentreportable segmentcapex2021-04-01 → 2022-03-31¥10.4bn
Medical Treatment Equipmentreportable segmentdepreciation2021-04-01 → 2022-03-31¥7.7bn
Medical Treatment Equipmentreportable segmentrevenue2021-04-01 → 2022-03-31¥54.6bn
Medical Treatment Equipmentreportable segmentrevenue external2021-04-01 → 2022-03-31¥54.6bn
Medical Treatment Equipmentreportable segmentsegment assetsat 2022-03-31¥48.1bn
Medical Treatment Equipmentreportable segmentsegment profit2021-04-01 → 2022-03-31¥11.5bn
Patient Monitoring Equipmentreportable segmentcapex2021-04-01 → 2022-03-31¥655m
Patient Monitoring Equipmentreportable segmentdepreciation2021-04-01 → 2022-03-31¥217m
Patient Monitoring Equipmentreportable segmentrevenue2021-04-01 → 2022-03-31¥12.9bn
Patient Monitoring Equipmentreportable segmentrevenue external2021-04-01 → 2022-03-31¥12.9bn
Patient Monitoring Equipmentreportable segmentsegment assetsat 2022-03-31¥9.9bn
Patient Monitoring Equipmentreportable segmentsegment profit2021-04-01 → 2022-03-31¥2.0bn
Physiological Diagnostic Equipmentreportable segmentcapex2021-04-01 → 2022-03-31¥1.5bn
Physiological Diagnostic Equipmentreportable segmentdepreciation2021-04-01 → 2022-03-31¥495m
Physiological Diagnostic Equipmentreportable segmentrevenue2021-04-01 → 2022-03-31¥29.4bn
Physiological Diagnostic Equipmentreportable segmentrevenue external2021-04-01 → 2022-03-31¥29.4bn
Physiological Diagnostic Equipmentreportable segmentsegment assetsat 2022-03-31¥19.9bn
Physiological Diagnostic Equipmentreportable segmentsegment profit2021-04-01 → 2022-03-31¥4.1bn
—segment totalemployeesat 2022-03-312650 pure
Total Of Reportable Segments And Otherssegment totalcapex2021-04-01 → 2022-03-31¥14.3bn
Total Of Reportable Segments And Otherssegment totaldepreciation2021-04-01 → 2022-03-31¥9.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2022-03-31¥132.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2022-03-31¥132.1bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥102.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2022-03-31¥22.7bn
Reconciling Itemsreconcilingsegment assetsat 2021-03-31¥88.7bn
Consumables And Other Productsreportable segmentcapex2020-04-01 → 2021-03-31¥1.6bn
Consumables And Other Productsreportable segmentdepreciation2020-04-01 → 2021-03-31¥495m
Consumables And Other Productsreportable segmentrevenue2020-04-01 → 2021-03-31¥37.0bn
Consumables And Other Productsreportable segmentrevenue external2020-04-01 → 2021-03-31¥37.0bn
Consumables And Other Productsreportable segmentsegment assetsat 2021-03-31¥22.5bn
Consumables And Other Productsreportable segmentsegment profit2020-04-01 → 2021-03-31¥4.5bn
Medical Treatment Equipmentreportable segmentcapex2020-04-01 → 2021-03-31¥9.3bn
Medical Treatment Equipmentreportable segmentdepreciation2020-04-01 → 2021-03-31¥7.1bn
Medical Treatment Equipmentreportable segmentrevenue2020-04-01 → 2021-03-31¥55.2bn
Medical Treatment Equipmentreportable segmentrevenue external2020-04-01 → 2021-03-31¥55.2bn
Medical Treatment Equipmentreportable segmentsegment assetsat 2021-03-31¥45.8bn
Medical Treatment Equipmentreportable segmentsegment profit2020-04-01 → 2021-03-31¥10.2bn
Patient Monitoring Equipmentreportable segmentcapex2020-04-01 → 2021-03-31¥604m
Patient Monitoring Equipmentreportable segmentdepreciation2020-04-01 → 2021-03-31¥188m
Patient Monitoring Equipmentreportable segmentrevenue2020-04-01 → 2021-03-31¥14.1bn
Patient Monitoring Equipmentreportable segmentrevenue external2020-04-01 → 2021-03-31¥14.1bn
Patient Monitoring Equipmentreportable segmentsegment assetsat 2021-03-31¥9.5bn
Patient Monitoring Equipmentreportable segmentsegment profit2020-04-01 → 2021-03-31¥1.8bn
Physiological Diagnostic Equipmentreportable segmentcapex2020-04-01 → 2021-03-31¥1.7bn
Physiological Diagnostic Equipmentreportable segmentdepreciation2020-04-01 → 2021-03-31¥542m
Physiological Diagnostic Equipmentreportable segmentrevenue2020-04-01 → 2021-03-31¥40.4bn
Physiological Diagnostic Equipmentreportable segmentrevenue external2020-04-01 → 2021-03-31¥40.4bn
Physiological Diagnostic Equipmentreportable segmentsegment assetsat 2021-03-31¥25.2bn
Physiological Diagnostic Equipmentreportable segmentsegment profit2020-04-01 → 2021-03-31¥3.3bn
Total Of Reportable Segments And Otherssegment totalcapex2020-04-01 → 2021-03-31¥13.3bn
Total Of Reportable Segments And Otherssegment totaldepreciation2020-04-01 → 2021-03-31¥8.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2020-04-01 → 2021-03-31¥146.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-04-01 → 2021-03-31¥146.8bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2021-03-31¥103.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2020-04-01 → 2021-03-31¥19.8bn
—segment totalemployeesat 2022-03-31549 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,664
ItemContextValueUnit
Net changes of items other than shareholders equityCurrentYearDuration215000000JPY
Total changes of items during the periodCurrentYearDuration_ValuationDifferenceOnAvailableForSaleSecuritiesMember31000000JPY
Total changes of items during the periodCurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember263000000JPY
Total changes of items during the periodCurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember-78000000JPY
Total changes of items during the periodCurrentYearDuration_ValuationAndTranslationAdjustmentsMember215000000JPY
Total changes of items during the periodCurrentYearDuration11876000000JPY
Net assetsCurrentYearInstant_ValuationDifferenceOnAvailableForSaleSecuritiesMember1836000000JPY
Net assetsCurrentYearInstant_ForeignCurrencyTranslationAdjustmentMember-11000000JPY
Net assetsCurrentYearInstant_RemeasurementsOfDefinedBenefitPlansMember-204000000JPY
Net assetsCurrentYearInstant_ValuationAndTranslationAdjustmentsMember1621000000JPY
Net assetsCurrentYearInstant149857000000JPY
Income before income taxesPrior1YearDuration21030000000JPY
Income before income taxesCurrentYearDuration23724000000JPY
Depreciation and amortization ope cfPrior1YearDuration8360000000JPY
Depreciation and amortization ope cfCurrentYearDuration9016000000JPY
Impairment loss ope cfPrior1YearDuration40000000JPY
Impairment loss ope cfCurrentYearDuration127000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YearDuration8000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYearDuration-39000000JPY
Increase decrease in provision for bonuses ope cfPrior1YearDuration465000000JPY
Increase decrease in provision for bonuses ope cfCurrentYearDuration245000000JPY
Increase decrease in provision for directors bonuses ope cfPrior1YearDuration139000000JPY
Increase decrease in provision for directors bonuses ope cfCurrentYearDuration143000000JPY
Increase decrease in provision for product warranties ope cfPrior1YearDuration-54000000JPY
Increase decrease in provision for product warranties ope cfCurrentYearDuration44000000JPY
Increase decrease in net defined benefit liability ope cfPrior1YearDuration-113000000JPY
Increase decrease in net defined benefit liability ope cfCurrentYearDuration277000000JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfPrior1YearDuration37000000JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfCurrentYearDuration22000000JPY
Increase decrease in provision for directors retirement benefits ope cfPrior1YearDuration21000000JPY
Increase decrease in provision for directors retirement benefits ope cfCurrentYearDuration24000000JPY
Interest and dividends income ope cfPrior1YearDuration-194000000JPY
Interest and dividends income ope cfCurrentYearDuration-199000000JPY
Interest expenses ope cfPrior1YearDuration39000000JPY
Interest expenses ope cfCurrentYearDuration37000000JPY
Loss gain on sales of noncurrent assets ope cfPrior1YearDuration-45000000JPY
Loss gain on sales of noncurrent assets ope cfCurrentYearDuration-4000000JPY
Loss gain on investments in partnership ope cfPrior1YearDuration-32000000JPY
Loss gain on investments in partnership ope cfCurrentYearDuration-63000000JPY
Loss gain on sales of investment securities ope cfPrior1YearDuration-762000000JPY
Loss gain on sales of investment securities ope cfCurrentYearDuration-60000000JPY
Loss gain on valuation of investment securities ope cfPrior1YearDuration411000000JPY
Loss gain on valuation of investment securities ope cfCurrentYearDuration-JPY
Loss gain on cancellation of insurance contract ope cfPrior1YearDuration-417000000JPY
Loss gain on cancellation of insurance contract ope cfCurrentYearDuration-404000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YearDuration-7864000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration6571000000JPY
Decrease increase in inventories ope cfPrior1YearDuration-476000000JPY
Decrease increase in inventories ope cfCurrentYearDuration-599000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YearDuration4528000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-03-31pass
statement vs summary · net assetsconsolidated 2021-03-31pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass